By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics developer Nuclea Biotechnologies and Clark University will establish a new center to use proteomics and metabolomics methods in conducting biomarker research focused on cancer, Nuclea said yesterday.

The Pittsfield, Mass.-based firm will expand an ongoing partnership with Clark to establish a new Proteomic and Metabolomic Center on the university's campus in Worcester.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.